E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers R > Headlines for Rich Pharmaceuticals, Inc. > News item
Published on 10/9/2014 in the Prospect News PIPE Daily.

Rich Pharmaceuticals could raise $4.5 million via investment agreement

Biopharmaceutical company negotiates agreement with Macallan Partners

By Devika Patel

Knoxville, Tenn., Oct. 9 – Rich Pharmaceuticals, Inc. said it negotiated a $4.5 million investment agreement with Macallan Partners, LLC.

The biopharmaceutical company is based in Beverly Hills, Calif.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.